Phase I Trial to Investigate Cafusertib Hydrochloride Monotherapy in Chinese Patients With Advanced Solid Tumours
Clinical trial NCT02314884 · UNKNOWN
Trial details
- NCT number
- NCT02314884
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2015-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.